Iloperidone
Brand name: Fanapt
Rank #355 of 500 drugs by total cost
$28.2M
Total Cost
13,925
Total Claims
$28.2M
Total Cost
662
Prescribers
$2,024
Cost per Claim
55
Beneficiaries
14,281
30-Day Fills
$43K
Avg Cost/Provider
21
Avg Claims/Provider
About Iloperidone
Iloperidone (sold as Fanapt) was prescribed 13,925 times by 662 Medicare Part D providers in 2023, costing the program $28.2M. At $2,024 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 352 | Pitolisant Hcl (Wakix) | $28.4M | 2,361 |
| 353 | Olanzapine/Samidorphan Malate (Lybalvi) | $28.3M | 18,294 |
| 354 | Interferon Beta-1b (Betaseron) | $28.3M | 2,983 |
| 355 | Iloperidone (Fanapt) | $28.2M | 13,925 |
| 356 | Aflibercept (Eylea) | $28.0M | 10,899 |
| 357 | Fostemsavir Tromethamine (Rukobia) | $27.8M | 3,094 |
| 358 | Colchicine (Colchicine) | $27.5M | 314,046 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology